John DeLuca, PhD

At the 2018 CMSC Annual Meeting, Dr. Deluca discusses the role of cognitive rehabilitation in MS.


Limelight Video

Next Article:

Cladribine Tablets Improve MRI Outcomes in Patients With Highly Active Relapsing-Remitting MS

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Related Articles